CPhI Online

- Biopharma News

Novel customizable and flexible single-use assembly solution

29 Sep 2020

Hugh Purity New England's solution can utilize other vendors' components and can be implemented directly into any process.

Demand for single-use assembly solutions in the biopharma industry continues to increase, with the market expected to be worth $26.89 billion by 2025.

To help meet that demand, High Purity New England (HPNE), a supplier of biopharma equipment and process solutions for the biopharma industry, has created HPConnexx, a single-use assembly solution suitable for all areas of biopharmaceutical processing from discovery to fill-finish.

Manufactured in an ISO 7 Cleanroom, the solution can utilize other vendors' components and can be implemented directly into any process.

“The solution, and the support we deliver around it, is truly unique as it can be customized in any way the customer requires. It can be connected to any existing process at any scale and utilize any components regardless of inter-company connectivity," explained the company's CEO and founder, Mark Sitcoske.

There is no minimum order size for an assembly and lead times can be as short as weeks, compared with the industry standard of months.

The team at HPNE also provide full integrity and validation testing on its single-use assemblies.

Sitcoske added: “Single-use technologies can reduce the costs associated with infrastructure, save time by decreasing the need for cleaning and validation and negate the risk of cross contamination. However, not all single-use solutions are fully customizable, and many have lengthy lead times for installation. That is why we developed HPConnexx.”

Related Categories

Related Content